APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Anti-Migraine Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Anti-Migraine Drugs Industry Growth and Trends Forecast to 2032

Report ID 173965190127 December 2025102 pages

Choose your research edition.

Industry ResearchAnti-Migraine Drugs Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-Migraine Drugs Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Anti-Migraine Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-Migraine Drugs Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-Migraine Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Anti-Migraine Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Anti-Migraine Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Anti-Migraine Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-Migraine Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti-Migraine Drugs include Allergan, Endo, Impax Laboratories, AstraZeneca, Amgen, Bayer, GlaxoSmithKline, Pfizer and Eli Lilly, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Anti-Migraine Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Anti-Migraine Drugs market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anti-Migraine Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anti-Migraine Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Anti-Migraine Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Anti-Migraine Drugs Market by Company

Allergan

Endo

Impax Laboratories

AstraZeneca

Amgen

Bayer

GlaxoSmithKline

Pfizer

Eli Lilly

Merck

Johnson & Johnson

Teva

Eisai

Abbott

Anti-Migraine Drugs Segment by Type

Ergots

Triptans

Others

Anti-Migraine Drugs Segment by Application

Women

Men

Anti-Migraine Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Migraine Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-Migraine Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Migraine Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti-Migraine Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Anti-Migraine Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Ergots Table 2. Major Company of Triptans Table 3. Major Company of Others Table 4. Global Anti-Migraine Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Anti-Migraine Drugs Sales by Type (2021-2026) & (W Units) Table 6. Global Anti-Migraine Drugs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Anti-Migraine Drugs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Anti-Migraine Drugs Sales Market Share in Value by Type (2021-2026) Table 9. Global Anti-Migraine Drugs Price by Type (2021-2026) & (US$/Unit) Table 10. Global Anti-Migraine Drugs Sales by Type (2027-2032) & (W Units) Table 11. Global Anti-Migraine Drugs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Anti-Migraine Drugs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Anti-Migraine Drugs Sales Market Share in Value by Type (2027-2032) Table 14. Global Anti-Migraine Drugs Price by Type (2027-2032) & (US$/Unit) Table 15. North America Anti-Migraine Drugs Sales by Type (2021-2026) & (W Units) Table 16. North America Anti-Migraine Drugs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Anti-Migraine Drugs Sales by Type (2021-2026) & (W Units) Table 18. Europe Anti-Migraine Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Anti-Migraine Drugs Sales by Type (2021-2026) & (W Units) Table 20. Asia-Pacific Anti-Migraine Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Anti-Migraine Drugs Sales by Type (2021-2026) & (W Units) Table 22. Latin America Anti-Migraine Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Anti-Migraine Drugs Sales by Type (2021-2026) & (W Units) Table 24. Middle East and Africa Anti-Migraine Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Anti-Migraine Drugs Industry Trends Table 26. Anti-Migraine Drugs Industry Drivers Table 27. Anti-Migraine Drugs Industry Opportunities and Challenges Table 28. Anti-Migraine Drugs Industry Restraints Table 29. Global Anti-Migraine Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Anti-Migraine Drugs Revenue Market Share by Company (2021-2026) Table 31. Global Anti-Migraine Drugs Sales by Company (2021-2026) & (W Units) Table 32. Global Anti-Migraine Drugs Sales Share by Company (2021-2026) Table 33. Global Anti-Migraine Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Anti-Migraine Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Anti-Migraine Drugs Major Company Production Sites and Headquarters Table 36. Global Anti-Migraine Drugs Company, Product Type & Application Table 37. Global Anti-Migraine Drugs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Anti-Migraine Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Anti-Migraine Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Anti-Migraine Drugs Sales by Region (2021-2026) & (W Units) Table 42. Global Anti-Migraine Drugs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Anti-Migraine Drugs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Anti-Migraine Drugs Sales Market Share in Value by Region (2021-2026) Table 45. Global Anti-Migraine Drugs Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Anti-Migraine Drugs Sales by Region (2027-2032) & (W Units) Table 47. Global Anti-Migraine Drugs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Anti-Migraine Drugs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Anti-Migraine Drugs Sales Market Share in Value by Region (2027-2032) Table 50. Global Anti-Migraine Drugs Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Anti-Migraine Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Anti-Migraine Drugs Sales by Application (2021-2026) & (W Units) Table 53. Global Anti-Migraine Drugs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Anti-Migraine Drugs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Anti-Migraine Drugs Sales Market Share in Value by Application (2021-2026) Table 56. Global Anti-Migraine Drugs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Anti-Migraine Drugs Sales by Application (2027-2032) & (W Units) Table 58. Global Anti-Migraine Drugs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Anti-Migraine Drugs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Anti-Migraine Drugs Sales Market Share in Value by Application (2027-2032) Table 61. Global Anti-Migraine Drugs Price by Application (2027-2032) & (US$/Unit) Table 62. North America Anti-Migraine Drugs Sales by Application (2021-2026) & (W Units) Table 63. North America Anti-Migraine Drugs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Anti-Migraine Drugs Sales by Application (2021-2026) & (W Units) Table 65. Europe Anti-Migraine Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Anti-Migraine Drugs Sales by Application (2021-2026) & (W Units) Table 67. Asia-Pacific Anti-Migraine Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Anti-Migraine Drugs Sales by Application (2021-2026) & (W Units) Table 69. Latin America Anti-Migraine Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Anti-Migraine Drugs Sales by Application (2021-2026) & (W Units) Table 71. Middle East and Africa Anti-Migraine Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Allergan Company Information Table 73. Allergan Business Overview Table 74. Allergan Anti-Migraine Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Allergan Anti-Migraine Drugs Product Portfolio Table 76. Allergan Recent Development Table 77. Endo Company Information Table 78. Endo Business Overview Table 79. Endo Anti-Migraine Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Endo Anti-Migraine Drugs Product Portfolio Table 81. Endo Recent Development Table 82. Impax Laboratories Company Information Table 83. Impax Laboratories Business Overview Table 84. Impax Laboratories Anti-Migraine Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Impax Laboratories Anti-Migraine Drugs Product Portfolio Table 86. Impax Laboratories Recent Development Table 87. AstraZeneca Company Information Table 88. AstraZeneca Business Overview Table 89. AstraZeneca Anti-Migraine Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. AstraZeneca Anti-Migraine Drugs Product Portfolio Table 91. AstraZeneca Recent Development Table 92. Amgen Company Information Table 93. Amgen Business Overview Table 94. Amgen Anti-Migraine Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Amgen Anti-Migraine Drugs Product Portfolio Table 96. Amgen Recent Development Table 97. Bayer Company Information Table 98. Bayer Business Overview Table 99. Bayer Anti-Migraine Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Bayer Anti-Migraine Drugs Product Portfolio Table 101. Bayer Recent Development Table 102. GlaxoSmithKline Company Information Table 103. GlaxoSmithKline Business Overview Table 104. GlaxoSmithKline Anti-Migraine Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. GlaxoSmithKline Anti-Migraine Drugs Product Portfolio Table 106. GlaxoSmithKline Recent Development Table 107. Pfizer Company Information Table 108. Pfizer Business Overview Table 109. Pfizer Anti-Migraine Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Pfizer Anti-Migraine Drugs Product Portfolio Table 111. Pfizer Recent Development Table 112. Eli Lilly Company Information Table 113. Eli Lilly Business Overview Table 114. Eli Lilly Anti-Migraine Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Eli Lilly Anti-Migraine Drugs Product Portfolio Table 116. Eli Lilly Recent Development Table 117. Merck Company Information Table 118. Merck Business Overview Table 119. Merck Anti-Migraine Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Merck Anti-Migraine Drugs Product Portfolio Table 121. Merck Recent Development Table 122. Johnson & Johnson Company Information Table 123. Johnson & Johnson Business Overview Table 124. Johnson & Johnson Anti-Migraine Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Johnson & Johnson Anti-Migraine Drugs Product Portfolio Table 126. Johnson & Johnson Recent Development Table 127. Teva Company Information Table 128. Teva Business Overview Table 129. Teva Anti-Migraine Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Teva Anti-Migraine Drugs Product Portfolio Table 131. Teva Recent Development Table 132. Eisai Company Information Table 133. Eisai Business Overview Table 134. Eisai Anti-Migraine Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Eisai Anti-Migraine Drugs Product Portfolio Table 136. Eisai Recent Development Table 137. Abbott Company Information Table 138. Abbott Business Overview Table 139. Abbott Anti-Migraine Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Abbott Anti-Migraine Drugs Product Portfolio Table 141. Abbott Recent Development Table 142. North America Anti-Migraine Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 143. North America Anti-Migraine Drugs Sales by Country (2021-2026) & (W Units) Table 144. North America Anti-Migraine Drugs Sales Market Share by Country (2021-2026) Table 145. North America Anti-Migraine Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 146. North America Anti-Migraine Drugs Sales Market Share Forecast by Country (2027-2032) Table 147. North America Anti-Migraine Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. North America Anti-Migraine Drugs Market Size by Country (2021-2026) & (US$ Million) Table 149. North America Anti-Migraine Drugs Market Share by Country (2021-2026) Table 150. North America Anti-Migraine Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. North America Anti-Migraine Drugs Market Share Forecast by Country (2027-2032) Table 152. Europe Anti-Migraine Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 153. Europe Anti-Migraine Drugs Sales by Country (2021-2026) & (W Units) Table 154. Europe Anti-Migraine Drugs Sales Market Share by Country (2021-2026) Table 155. Europe Anti-Migraine Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 156. Europe Anti-Migraine Drugs Sales Market Share Forecast by Country (2027-2032) Table 157. Europe Anti-Migraine Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Europe Anti-Migraine Drugs Market Size by Country (2021-2026) & (US$ Million) Table 159. Europe Anti-Migraine Drugs Market Share by Country (2021-2026) Table 160. Europe Anti-Migraine Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Europe Anti-Migraine Drugs Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Anti-Migraine Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Anti-Migraine Drugs Sales by Country (2021-2026) & (W Units) Table 164. Asia-Pacific Anti-Migraine Drugs Sales Market Share by Country (2021-2026) Table 165. Asia-Pacific Anti-Migraine Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 166. Asia-Pacific Anti-Migraine Drugs Sales Market Share Forecast by Country (2027-2032) Table 167. Asia-Pacific Anti-Migraine Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Asia-Pacific Anti-Migraine Drugs Market Size by Country (2021-2026) & (US$ Million) Table 169. Asia-Pacific Anti-Migraine Drugs Market Share by Country (2021-2026) Table 170. Asia-Pacific Anti-Migraine Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Asia-Pacific Anti-Migraine Drugs Market Share Forecast by Country (2027-2032) Table 172. Latin America Anti-Migraine Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 173. Latin America Anti-Migraine Drugs Sales by Country (2021-2026) & (W Units) Table 174. Latin America Anti-Migraine Drugs Sales Market Share by Country (2021-2026) Table 175. Latin America Anti-Migraine Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 176. Latin America Anti-Migraine Drugs Sales Market Share Forecast by Country (2027-2032) Table 177. Latin America Anti-Migraine Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Latin America Anti-Migraine Drugs Market Size by Country (2021-2026) & (US$ Million) Table 179. Latin America Anti-Migraine Drugs Market Share by Country (2021-2026) Table 180. Latin America Anti-Migraine Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Latin America Anti-Migraine Drugs Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Anti-Migraine Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Anti-Migraine Drugs Sales by Country (2021-2026) & (W Units) Table 184. Middle East and Africa Anti-Migraine Drugs Sales Market Share by Country (2021-2026) Table 185. Middle East and Africa Anti-Migraine Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 186. Middle East and Africa Anti-Migraine Drugs Sales Market Share Forecast by Country (2027-2032) Table 187. Middle East and Africa Anti-Migraine Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Middle East and Africa Anti-Migraine Drugs Market Size by Country (2021-2026) & (US$ Million) Table 189. Middle East and Africa Anti-Migraine Drugs Market Share by Country (2021-2026) Table 190. Middle East and Africa Anti-Migraine Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Middle East and Africa Anti-Migraine Drugs Market Share Forecast by Country (2027-2032) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Anti-Migraine Drugs Distributors List Table 195. Anti-Migraine Drugs Customers List Table 196. Research Programs/Design for This Report Table 197. Authors List of This Report Table 198. Secondary Sources Table 199. Primary Sources List of Figures Figure 1. Anti-Migraine Drugs Image Figure 2. Global Anti-Migraine Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-Migraine Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-Migraine Drugs Sales (2021-2032) & (W Units) Figure 5. Ergots Image Figure 6. Global Ergots Sales YoY Growth (2021-2032) & (W Units) Figure 7. Triptans Image Figure 8. Global Triptans Sales YoY Growth (2021-2032) & (W Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 11. Global Anti-Migraine Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Anti-Migraine Drugs Market Share by Type 2025 VS 2032 Figure 13. North America Anti-Migraine Drugs Sales Market Share in Volume by Type in 2025 Figure 14. North America Anti-Migraine Drugs Sales Market Share in Value by Type in 2025 Figure 15. Europe Anti-Migraine Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Anti-Migraine Drugs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Anti-Migraine Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Anti-Migraine Drugs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Anti-Migraine Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Anti-Migraine Drugs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Anti-Migraine Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Anti-Migraine Drugs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Anti-Migraine Drugs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Women Image Figure 26. Global Women Sales YoY Growth (2021-2032) & (W Units) Figure 27. Men Image Figure 28. Global Men Sales YoY Growth (2021-2032) & (W Units) Figure 29. Global Anti-Migraine Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Anti-Migraine Drugs Market Share by Application 2025 VS 2032 Figure 31. North America Anti-Migraine Drugs Sales Market Share in Volume by Application in 2025 Figure 32. North America Anti-Migraine Drugs Sales Market Share in Value by Application in 2025 Figure 33. Europe Anti-Migraine Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Europe Anti-Migraine Drugs Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Anti-Migraine Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Anti-Migraine Drugs Sales Market Share in Value by Application in 2025 Figure 37. Latin America Anti-Migraine Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Anti-Migraine Drugs Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Anti-Migraine Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Anti-Migraine Drugs Sales Market Share in Value by Application in 2025 Figure 41. North America Anti-Migraine Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 42. North America Anti-Migraine Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Anti-Migraine Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Anti-Migraine Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Anti-Migraine Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 46. Europe Anti-Migraine Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Anti-Migraine Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Anti-Migraine Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Anti-Migraine Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. Asia-Pacific Anti-Migraine Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Anti-Migraine Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Anti-Migraine Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Anti-Migraine Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Latin America Anti-Migraine Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Anti-Migraine Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Anti-Migraine Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Anti-Migraine Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Middle East and Africa Anti-Migraine Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Anti-Migraine Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Anti-Migraine Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Anti-Migraine Drugs Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Anti-Migraine Drugs Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Ergots
  • Triptans
  • Others
Applications
  • Women
  • Men
Companies covered
  • Allergan
  • Endo
  • Impax Laboratories
  • AstraZeneca
  • Amgen
  • Bayer
  • GlaxoSmithKline
  • Pfizer
  • Eli Lilly
  • Merck
  • Johnson & Johnson
  • Teva
  • Eisai
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anti-Migraine Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Anti-Migraine Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Anti-Migraine Drugs Market by Type
  6. 1.3.1 Ergots
  7. 1.3.2 Triptans
  8. 1.3.3 Others
  9. 1.4 Global Anti-Migraine Drugs Market Size by Type
  10. 1.4.1 Global Anti-Migraine Drugs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Anti-Migraine Drugs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Anti-Migraine Drugs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Anti-Migraine Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Anti-Migraine Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Anti-Migraine Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Anti-Migraine Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Anti-Migraine Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Anti-Migraine Drugs Industry Trends
  2. 2.2 Anti-Migraine Drugs Industry Drivers
  3. 2.3 Anti-Migraine Drugs Industry Opportunities and Challenges
  4. 2.4 Anti-Migraine Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Anti-Migraine Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Anti-Migraine Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Anti-Migraine Drugs Price (2021-2026)
  4. 3.4 Global Anti-Migraine Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anti-Migraine Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Anti-Migraine Drugs Company, Product Type & Application
  7. 3.7 Global Anti-Migraine Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anti-Migraine Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anti-Migraine Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anti-Migraine Drugs Tier 1, Tier 2, and Tier 3
4 Anti-Migraine Drugs Regional Status and Outlook
  1. 4.1 Global Anti-Migraine Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Anti-Migraine Drugs Historic Market Size by Region
  3. 4.2.1 Global Anti-Migraine Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Anti-Migraine Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Anti-Migraine Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Anti-Migraine Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Anti-Migraine Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Anti-Migraine Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Anti-Migraine Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Anti-Migraine Drugs by Application
  1. 5.1 Anti-Migraine Drugs Market by Application
  2. 5.1.1 Women
  3. 5.1.2 Men
  4. 5.2 Global Anti-Migraine Drugs Market Size by Application
  5. 5.2.1 Global Anti-Migraine Drugs Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Anti-Migraine Drugs Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Anti-Migraine Drugs Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Anti-Migraine Drugs Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Anti-Migraine Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Anti-Migraine Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Anti-Migraine Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Anti-Migraine Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Allergan
  2. 6.1.1 Allergan Company Information
  3. 6.1.2 Allergan Business Overview
  4. 6.1.3 Allergan Anti-Migraine Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Allergan Anti-Migraine Drugs Product Portfolio
  6. 6.1.5 Allergan Recent Developments
  7. 6.2 Endo
  8. 6.2.1 Endo Company Information
  9. 6.2.2 Endo Business Overview
  10. 6.2.3 Endo Anti-Migraine Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Endo Anti-Migraine Drugs Product Portfolio
  12. 6.2.5 Endo Recent Developments
  13. 6.3 Impax Laboratories
  14. 6.3.1 Impax Laboratories Company Information
  15. 6.3.2 Impax Laboratories Business Overview
  16. 6.3.3 Impax Laboratories Anti-Migraine Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Impax Laboratories Anti-Migraine Drugs Product Portfolio
  18. 6.3.5 Impax Laboratories Recent Developments
  19. 6.4 AstraZeneca
  20. 6.4.1 AstraZeneca Company Information
  21. 6.4.2 AstraZeneca Business Overview
  22. 6.4.3 AstraZeneca Anti-Migraine Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 AstraZeneca Anti-Migraine Drugs Product Portfolio
  24. 6.4.5 AstraZeneca Recent Developments
  25. 6.5 Amgen
  26. 6.5.1 Amgen Company Information
  27. 6.5.2 Amgen Business Overview
  28. 6.5.3 Amgen Anti-Migraine Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Amgen Anti-Migraine Drugs Product Portfolio
  30. 6.5.5 Amgen Recent Developments
  31. 6.6 Bayer
  32. 6.6.1 Bayer Company Information
  33. 6.6.2 Bayer Business Overview
  34. 6.6.3 Bayer Anti-Migraine Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Bayer Anti-Migraine Drugs Product Portfolio
  36. 6.6.5 Bayer Recent Developments
  37. 6.7 GlaxoSmithKline
  38. 6.7.1 GlaxoSmithKline Company Information
  39. 6.7.2 GlaxoSmithKline Business Overview
  40. 6.7.3 GlaxoSmithKline Anti-Migraine Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GlaxoSmithKline Anti-Migraine Drugs Product Portfolio
  42. 6.7.5 GlaxoSmithKline Recent Developments
  43. 6.8 Pfizer
  44. 6.8.1 Pfizer Company Information
  45. 6.8.2 Pfizer Business Overview
  46. 6.8.3 Pfizer Anti-Migraine Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Pfizer Anti-Migraine Drugs Product Portfolio
  48. 6.8.5 Pfizer Recent Developments
  49. 6.9 Eli Lilly
  50. 6.9.1 Eli Lilly Company Information
  51. 6.9.2 Eli Lilly Business Overview
  52. 6.9.3 Eli Lilly Anti-Migraine Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Eli Lilly Anti-Migraine Drugs Product Portfolio
  54. 6.9.5 Eli Lilly Recent Developments
  55. 6.10 Merck
  56. 6.10.1 Merck Company Information
  57. 6.10.2 Merck Business Overview
  58. 6.10.3 Merck Anti-Migraine Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Merck Anti-Migraine Drugs Product Portfolio
  60. 6.10.5 Merck Recent Developments
  61. 6.11 Johnson & Johnson
  62. 6.11.1 Johnson & Johnson Company Information
  63. 6.11.2 Johnson & Johnson Business Overview
  64. 6.11.3 Johnson & Johnson Anti-Migraine Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Johnson & Johnson Anti-Migraine Drugs Product Portfolio
  66. 6.11.5 Johnson & Johnson Recent Developments
  67. 6.12 Teva
  68. 6.12.1 Teva Company Information
  69. 6.12.2 Teva Business Overview
  70. 6.12.3 Teva Anti-Migraine Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Teva Anti-Migraine Drugs Product Portfolio
  72. 6.12.5 Teva Recent Developments
  73. 6.13 Eisai
  74. 6.13.1 Eisai Company Information
  75. 6.13.2 Eisai Business Overview
  76. 6.13.3 Eisai Anti-Migraine Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Eisai Anti-Migraine Drugs Product Portfolio
  78. 6.13.5 Eisai Recent Developments
  79. 6.14 Abbott
  80. 6.14.1 Abbott Company Information
  81. 6.14.2 Abbott Business Overview
  82. 6.14.3 Abbott Anti-Migraine Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Abbott Anti-Migraine Drugs Product Portfolio
  84. 6.14.5 Abbott Recent Developments
7 North America by Country
  1. 7.1 North America Anti-Migraine Drugs Sales by Country
  2. 7.1.1 North America Anti-Migraine Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Anti-Migraine Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Anti-Migraine Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Anti-Migraine Drugs Market Size by Country
  6. 7.2.1 North America Anti-Migraine Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Anti-Migraine Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Anti-Migraine Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Anti-Migraine Drugs Sales by Country
  2. 8.1.1 Europe Anti-Migraine Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Anti-Migraine Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Anti-Migraine Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Anti-Migraine Drugs Market Size by Country
  6. 8.2.1 Europe Anti-Migraine Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Anti-Migraine Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Anti-Migraine Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Anti-Migraine Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Anti-Migraine Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Anti-Migraine Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Anti-Migraine Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Anti-Migraine Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Anti-Migraine Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Anti-Migraine Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Anti-Migraine Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Anti-Migraine Drugs Sales by Country
  2. 10.1.1 South America Anti-Migraine Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Anti-Migraine Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Anti-Migraine Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Anti-Migraine Drugs Market Size by Country
  6. 10.2.1 South America Anti-Migraine Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Anti-Migraine Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Anti-Migraine Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Anti-Migraine Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Anti-Migraine Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Anti-Migraine Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Anti-Migraine Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Anti-Migraine Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Anti-Migraine Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Anti-Migraine Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Anti-Migraine Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Anti-Migraine Drugs Value Chain Analysis
  2. 12.1.1 Anti-Migraine Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Anti-Migraine Drugs Production Mode & Process
  7. 12.2 Anti-Migraine Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Anti-Migraine Drugs Distributors
  10. 12.2.3 Anti-Migraine Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst